See more : RENDER (RND.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Qol Holdings Co., Ltd. (3034.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Qol Holdings Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Organon & Co. (OGN) Income Statement Analysis – Financial Results
- Sumedha Fiscal Services Limited (SUMEDHA.BO) Income Statement Analysis – Financial Results
- Lockheed Martin Corporation (LMT.SW) Income Statement Analysis – Financial Results
- Blue Star Global, Inc. (BUSC) Income Statement Analysis – Financial Results
- Kairos Minerals Limited (KAI.AX) Income Statement Analysis – Financial Results
Qol Holdings Co., Ltd. (3034.T)
About Qol Holdings Co., Ltd.
Qol Holdings Co., Ltd., together with its subsidiaries, engages in dispensing pharmacy and business process outsourcing contracting businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also undertakes sales and marketing research activities for pharmaceutical companies; and provides temporary staff dispatch for pharmacists, nurses, registered sellers, registered dietitians, etc. In addition, the company offers clinical trial support services for pharmaceuticals and food products; support, monitoring, and technician dispatch services of managers for various processes, from planning of trial execution plans to monitoring, secretariat support, statistical analysis, and the presentation of conference papers; and publishing related services. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. Qol Holdings Co., Ltd. was founded in 1992 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 180.05B | 170.04B | 166.20B | 161.83B | 165.41B | 144.78B | 145.52B | 131.50B | 124.96B | 114.36B | 100.97B | 76.78B | 66.20B | 60.92B | 56.31B | 49.01B | 38.00B | 24.83B | 21.70B | 20.19B |
| Cost of Revenue | 160.20B | 146.53B | 143.04B | 140.73B | 144.32B | 126.92B | 125.87B | 114.63B | 109.20B | 100.37B | 90.07B | 67.36B | 57.68B | 53.29B | 49.83B | 43.85B | 33.87B | 22.12B | 19.42B | 18.10B |
| Gross Profit | 19.86B | 23.51B | 23.16B | 21.10B | 21.09B | 17.86B | 19.65B | 16.88B | 15.76B | 13.99B | 10.90B | 9.42B | 8.53B | 7.62B | 6.48B | 5.16B | 4.14B | 2.70B | 2.29B | 2.09B |
| Gross Profit Ratio | 11.03% | 13.82% | 13.94% | 13.04% | 12.75% | 12.34% | 13.50% | 12.83% | 12.61% | 12.23% | 10.79% | 12.27% | 12.88% | 12.51% | 11.51% | 10.53% | 10.88% | 10.89% | 10.53% | 10.35% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.53B | 10.81B | 10.14B | 10.65B | 10.29B | 8.41B | 8.22B | 8.06B | 7.59B | 8.25B | 7.62B | 5.92B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 463.00M | 333.00M | 148.00M | 182.00M | 194.00M | 291.00M | 86.00M | 115.00M | 90.00M | 108.00M | 53.00M | 1.62M | 82.87M | 52.15M | 32.14M | 2.84M | -23.09M | 26.53M | 40.59M |
| Operating Expenses | 14.93B | 14.01B | 13.31B | 13.74B | 13.36B | 10.81B | 10.56B | 10.01B | 9.05B | 9.75B | 8.79B | 6.61B | 5.22B | 4.82B | 4.48B | 3.66B | 2.84B | 1.77B | 1.51B | 1.48B |
| Cost & Expenses | 171.73B | 160.54B | 156.34B | 154.47B | 157.68B | 137.73B | 136.42B | 124.64B | 118.25B | 110.12B | 98.86B | 73.97B | 62.89B | 58.11B | 54.30B | 47.51B | 36.71B | 23.89B | 20.92B | 19.58B |
| Interest Income | 0.00 | 89.00M | 101.00M | 112.00M | 119.00M | 94.00M | 0.00 | 0.00 | 0.00 | 0.00 | 22.00M | 9.00M | 16.60M | 12.59M | 10.41M | 8.97M | 16.34M | 2.27M | 2.25M | 3.72M |
| Interest Expense | 109.00M | 89.00M | 101.00M | 112.00M | 119.00M | 94.00M | 103.00M | 106.00M | 117.00M | 133.00M | 118.00M | 80.00M | 54.33M | 64.12M | 60.67M | 61.46M | 64.65M | 50.07M | 50.72M | 75.07M |
| Depreciation & Amortization | 5.24B | 4.88B | 4.73B | 4.67B | 4.62B | 4.12B | 3.96B | 3.53B | 3.18B | 3.11B | 2.75B | 2.18B | 1.80B | 1.57B | 1.23B | 1.28B | 684.31M | 374.27M | 254.59M | 204.95M |
| EBITDA | 14.21B | 14.56B | 14.52B | 11.67B | 12.42B | 11.38B | 12.48B | 10.82B | 9.59B | 7.12B | 4.86B | 4.99B | 5.10B | 4.15B | 3.08B | 2.72B | 2.03B | 1.28B | 1.05B | 860.79M |
| EBITDA Ratio | 7.89% | 8.73% | 8.98% | 7.53% | 7.58% | 7.85% | 9.17% | 7.97% | 8.00% | 6.51% | 4.91% | 6.58% | 7.70% | 7.30% | 5.86% | 5.76% | 5.33% | 5.20% | 4.90% | 4.26% |
| Operating Income | 8.33B | 9.50B | 9.86B | 7.36B | 7.73B | 7.05B | 9.09B | 6.87B | 6.71B | 4.24B | 2.11B | 2.81B | 3.31B | 2.80B | 2.00B | 1.50B | 1.30B | 937.95M | 779.16M | 611.52M |
| Operating Income Ratio | 4.62% | 5.58% | 5.93% | 4.55% | 4.68% | 4.87% | 6.25% | 5.22% | 5.37% | 3.71% | 2.08% | 3.66% | 5.00% | 4.60% | 3.55% | 3.07% | 3.41% | 3.78% | 3.59% | 3.03% |
| Total Other Income/Expenses | 535.00M | 89.00M | -168.00M | -470.00M | -149.00M | 115.00M | -680.00M | 315.00M | -347.00M | -361.00M | -111.00M | -85.00M | -297.69M | -316.53M | -218.18M | -117.67M | -155.48M | -80.68M | -34.09M | -385.47M |
| Income Before Tax | 8.86B | 9.58B | 9.69B | 6.90B | 7.68B | 7.17B | 8.41B | 7.18B | 6.40B | 3.88B | 1.99B | 2.73B | 3.01B | 2.49B | 1.78B | 1.38B | 1.14B | 857.27M | 745.07M | 226.06M |
| Income Before Tax Ratio | 4.92% | 5.64% | 5.83% | 4.26% | 4.64% | 4.95% | 5.78% | 5.46% | 5.12% | 3.39% | 1.97% | 3.55% | 4.55% | 4.08% | 3.17% | 2.83% | 3.00% | 3.45% | 3.43% | 1.12% |
| Income Tax Expense | 3.98B | 3.93B | 4.19B | 3.34B | 3.41B | 3.19B | 3.39B | 2.77B | 2.70B | 1.72B | 1.20B | 1.33B | 1.45B | 1.35B | 954.61M | 729.67M | 592.27M | 453.35M | 411.74M | 152.05M |
| Net Income | 4.88B | 5.66B | 5.49B | 3.37B | 4.07B | 3.91B | 4.99B | 4.35B | 3.64B | 2.16B | 777.00M | 1.35B | 1.56B | 1.14B | 828.44M | 653.80M | 547.37M | 403.92M | 333.33M | 74.01M |
| Net Income Ratio | 2.71% | 3.33% | 3.30% | 2.08% | 2.46% | 2.70% | 3.43% | 3.31% | 2.91% | 1.88% | 0.77% | 1.76% | 2.36% | 1.87% | 1.47% | 1.33% | 1.44% | 1.63% | 1.54% | 0.37% |
| EPS | 131.10 | 152.95 | 149.49 | 89.53 | 107.22 | 101.70 | 130.19 | 128.35 | 107.78 | 63.33 | 25.11 | 52.76 | 62.11 | 45.94 | 33.47 | 52.83 | 29.87 | 34.12 | 79.68 | 2.99 |
| EPS Diluted | 131.10 | 152.95 | 149.49 | 89.53 | 107.22 | 101.70 | 130.19 | 128.35 | 100.80 | 63.33 | 25.11 | 52.76 | 62.11 | 45.94 | 33.47 | 52.83 | 29.87 | 34.12 | 79.68 | 2.99 |
| Weighted Avg Shares Out | 37.22M | 36.98M | 36.72M | 37.59M | 37.93M | 38.43M | 38.30M | 33.92M | 34.41M | 34.04M | 30.96M | 25.58M | 25.12M | 24.75M | 24.75M | 12.37M | 24.75M | 11.84M | 24.75M | 24.75M |
| Weighted Avg Shares Out (Dil) | 37.22M | 36.98M | 36.72M | 37.59M | 37.93M | 38.43M | 38.30M | 33.92M | 36.80M | 34.04M | 30.96M | 25.58M | 25.12M | 24.75M | 24.75M | 12.37M | 24.75M | 11.84M | 24.75M | 24.75M |
Source: https://incomestatements.info
Category: Stock Reports